Factors That Impact the Duration of MRI-Guided Core Needle Biopsy

Abstract

Variables that minimized procedure duration were number of image acquisitions, number of patient insertions or removals from the magnet, and assistance of a breast imaging fellow-in-training. No patient-related or target-related variables impacted procedure time.

High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: can underestimation be predicted?

“…Both frequency of high-risk lesions at MRgVABB and underestimation rates in our study are higher than previously reported in other studies (Table 4) evaluating outcomes of MR-guided breast biopsy [11,12,29,31,32]. This might be explained by the high pretest probability for breast cancer in our study population, which in addition to asymptomatic women undergoing screening MRI included a substantial proportion of diagnostic cases and patients with a personal history of breast carcinoma.…”

Performing MR-guided biopsies in clinical routine: factors that influence accuracy and procedure time

“…Several publications have addressed the value of MRI-guided biopsy in liver and musculoskeletal lesions and in some publications the total duration of the interventions were stated [16,17]. Attempts to reduce the intervention time in using MR-fluoroscopic guidance [18] have been reported, however only one publication has focused on factors that affect the duration of MR-guided breast biopsies [19].…”

Breast Magnetic Resonance Imaging-Guided Biopsy

“…Other rare complications are skin laceration, vasovagal syncope, and infection. Termination of the procedure due to a complication is rare (19,(27)(28)(29)(30)(31)(32)(33)(34)(35)(36).…”

“…MRI-guided biopsy has no corresponding evaluation method such as specimen imaging in stereotactic biopsy or real-time monitoring in ultrasound-guided biopsy; therefore, radiologic-pathologic concordance requires caution. The positive predictive value of a lesion detected by MRI with subsequent MRI-guided biopsy is 16-61%; a radiologist should be aware that for radiologic-pathologic correlation, the positive predictive value is affected by the prevalence of breast cancer in a patient population (19,30,33,36,(38)(39)(40). A six-month follow-up is recommended for a benign concordant biopsy result (41).…”

“…A six-month follow-up is recommended for a benign concordant biopsy result (41). The rate of radiology-pathology discordance is not high (0% to 10.7%); but the mean proportion of malignancies in discordant cases is 37.5%, and surgical excision is recommended for discordant lesions (Table 3) (19,29,30,34,36,38,39).…”